US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist

1.9250
-0.0250-1.28%

Trading Oct 2 11:59 ET

11.74MMarket Cap-740P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD

2023/FY

Stock NameRevenueRatio

Research and development of the Company’s drug candidates743K100.00%

Region Currency:USD

2023/FY

Stock NameRevenueRatio

Israel743K100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data